ARCHIVES

Is a New Cancer Center Always a Good Thing? UCSD To Buy Las Vegas Center at Bankruptcy Sale

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997